Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gallus

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
European Journal of Paediatric Dentistry|May 4, 2023
Effects of an Educational Book on Paediatric Oral Health knowledge in a sample of Italian womenS Colombo, S Friuli, S De Giorgio, et al.
Alimentary Pharmacology & Therapeutics|November 18, 2003
Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowelF Parente, S Greco, M Molteni, et al.
Blood|July 16, 2008
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging StudyHarry R Buller, Anthonie W A Lensing, Martin H Prins, et al.
The New England Journal of Medicine|September 15, 2007
Idraparinux versus standard therapy for venous thromboembolic disease, Harry R Buller, Ander T Cohen, et al.
The New England Journal of Medicine|September 15, 2007
Extended prophylaxis of venous thromboembolism with idraparinux, Harry R Buller, Ander T Cohen, et al.
Thrombosis and Haemostasis|September 2, 2016
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trialSuzanne M Bleker, Alexander T Cohen, Harry R Büller, et al.
The New England Journal of Medicine|July 2, 2013
Oral apixaban for the treatment of acute venous thromboembolismGiancarlo Agnelli, Harry R Buller, Alexander Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2009
Tobacco smoking, alcohol consumption and pancreatic cancer risk: a case-control study in ItalyR Talamini, J Polesel, S Gallus, et al.
Thrombosis and Haemostasis|May 29, 2010
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trialFrederiek F van Doormaal, Alexander T Cohen, Bruce L Davidson, et al.
The New England Journal of Medicine|March 14, 1996
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study GroupM M Koopman, P Prandoni, F Piovella, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
European Journal of Paediatric Dentistry|May 4, 2023
Effects of an Educational Book on Paediatric Oral Health knowledge in a sample of Italian womenS Colombo, S Friuli, S De Giorgio, et al.
Alimentary Pharmacology & Therapeutics|November 18, 2003
Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowelF Parente, S Greco, M Molteni, et al.
Blood|July 16, 2008
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging StudyHarry R Buller, Anthonie W A Lensing, Martin H Prins, et al.
The New England Journal of Medicine|September 15, 2007
Idraparinux versus standard therapy for venous thromboembolic disease, Harry R Buller, Ander T Cohen, et al.
The New England Journal of Medicine|September 15, 2007
Extended prophylaxis of venous thromboembolism with idraparinux, Harry R Buller, Ander T Cohen, et al.
Thrombosis and Haemostasis|September 2, 2016
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trialSuzanne M Bleker, Alexander T Cohen, Harry R Büller, et al.
The New England Journal of Medicine|July 2, 2013
Oral apixaban for the treatment of acute venous thromboembolismGiancarlo Agnelli, Harry R Buller, Alexander Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2009
Tobacco smoking, alcohol consumption and pancreatic cancer risk: a case-control study in ItalyR Talamini, J Polesel, S Gallus, et al.
Thrombosis and Haemostasis|May 29, 2010
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trialFrederiek F van Doormaal, Alexander T Cohen, Bruce L Davidson, et al.
The New England Journal of Medicine|March 14, 1996
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study GroupM M Koopman, P Prandoni, F Piovella, et al.
Pageof 15